Mar 25, 2016Business
Gilead ordered to pay Merck $200M for patent infringement

The federal jury in a patent trial has ordered drugmaker Gilead Sciences to pay Merck $200 million in damages for infringing on patents for hepatitis C drugs.

Gilead ordered to pay Merck $200M for patent infringement
A federal jury has ordered drugmaker Gilead Sciences to pay Merck $200 million in damages for infringing on patents for hepatitis C drugs.
Share
Amruta ThereGood read.. Thanks for sharing ...
Mar 27, 2016